Unlocking Hope: The Superior Efficacy of rTMS for Treatment-Resistant Depression
In a groundbreaking Harvard-led study, researchers such as Dr. Alexander Bystritsky have discovered a highly effective treatment for individuals suffering from Treatment-Resistant Depression (TRD). The study compared three different treatment plans and found that repetitive Transcranial Magnetic Stimulation (rTMS) combined with existing antidepressant medications significantly reduced depressive symptoms more than other treatment options. This new approach offers hope to those who have exhausted traditional therapies, highlighting rTMS as a promising solution for TRD.
Deep TMS H1 Coil treatment for depression: Results from a large post-marketing data analysis
Learn more about Deep TMS treatment for depression, revealing promising results in treating major depressive disorder (MDD). Learn about the study's major findings, the problem it addresses, and the solution it offers.
Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression
Transcranial magnetic stimulation (TMS) has been found to be an effective long-term treatment for patients with Treatment-Resistant Depression (TRD), with a low relapse rate, especially when followed by continued treatment protocols.
Durability of deep transcranial magnetic stimulation for veterans with treatment-resistant depression
A recent study highlights the effectiveness of Transcranial Magnetic Stimulation (TMS) in treating veterans with Treatment Resistant Depression (TRD), PTSD, and suicide risk. The treatment showed significant reductions in depressive and PTSD symptoms, and suicidal ideation, with improvements sustained up to six months post-treatment.